In March 2025, the company announced new strategies for just a direct-to-shopper giving of its Wegovy weight loss drug. The company established a whole new pharmacy, called NovoCare, which might charge consumers $499 monthly for entry to the drug, under fifty percent the expense of the drug by means of other pharmaceutical distribution networks.[fi